Skip to main content
Robert Spiera, MD, Rheumatology, New York, NY

RobertFSpieraMD

Rheumatology New York, NY

Professor of Clinical Medicine, Cornell University-Weill Medical College

Dr. Spiera is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spiera's full profile

Already have an account?

  • Office

    1088 Park Avenue
    New York, NY 10128
    Phone+1 212-860-2100
    Fax+1 212-722-7365

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1992 - 1995
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1992
  • Yale School of Medicine
    Yale School of MedicineClass of 1989
  • Columbia College
    Columbia CollegeB.A., Summa Cum Laude, 1981 - 1985

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1991 - 2025
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2013-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Rheumatology Teacher of the Year 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts  
    Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma  
    Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Walla..., N Engl J Med, 1/4/2018
  • A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis  
    Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pa..., Arthritis Rheumatol, 1/30/2017
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Outcome Measures in Giant Cell Arteritis and Polymyalgia Rheumatica
    Spiera RF, Fourth International Symposium on Giant Cell Arteritis & Polymyalgia Rheumatica, 1/1/2008
  • Extraintestinal Manifestations of Inflammatory Bowel Disease
    Spiera RF, American College of Gastroenterology, 1/1/2001
  • Ticlopidine Induced SLE: A Report of Four Cases
    Spiera RF, ACR National Meeting, 1/1/2000
  • Join now to see all

Lectures

  • Vasculitis 
    Multiple locations, 2002, 2003, 2004, 2007, 2015, 2016 - 1/1/2016
  • Temporal Arteritis 
    Multiple locations, 2000, 2001, 2009, 2013, 2014 - 1/1/2014
  • Participating in Research-How it Works & What is out There 
    New York, NY - 1/1/2014
  • Join now to see all

Authored Content

  • Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)November 2022
  • Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
  • Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
  • Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
  • Join now to see all

Press Mentions

  • New Drugs, Treatment Strategies Aim to Lessen Rheumatic Diseases’ Reliance on Steroids
    New Drugs, Treatment Strategies Aim to Lessen Rheumatic Diseases’ Reliance on SteroidsJuly 25th, 2024
  • Steroids’ 75th Anniversary: Clinicians Strive to Use Less
    Steroids’ 75th Anniversary: Clinicians Strive to Use LessJuly 25th, 2024
  • Lenabasum Improved Skin Symptoms in Dermatomyositis, but Future Is Uncertain
    Lenabasum Improved Skin Symptoms in Dermatomyositis, but Future Is UncertainMay 17th, 2022
  • Join now to see all

Professional Memberships